keyword
https://read.qxmd.com/read/38657291/gene-associations-of-lipid-traits-lipid-lowering-drug-target-genes-and-endometriosis
#1
JOURNAL ARTICLE
Ge Zhou, Jin Ren, Qiuyan Huang, Xiaowei Nie, Xingli Tong, Ya Wen Cui, Rongkui Hu, Qi Yao
RESEARCH QUESTION: Does the observed correlation between dyslipidaemia and endometriosis indicate a bidirectional causal association? DESIGN: Bidirectional Mendelian randomization was used to investigate the causal association between lipid traits and endometriosis. Drug-target Mendelian randomization was used to explore potential drug-target genes for managing endometriosis. In cases where lipid-mediated effects via specific drug targets were significant, aggregate analyses, such as summary-data-based Mendelian randomization and colocalization methods, were introduced to validate the outcomes...
February 2, 2024: Reproductive Biomedicine Online
https://read.qxmd.com/read/38657290/clinical-factors-associated-with-unexpected-poor-or-suboptimal-response-in-poseidon-criteria-patients
#2
JOURNAL ARTICLE
Alyssa Hochberg, Michael H Dahan, Hakan Yarali, Lan N Vuong, Sandro C Esteves
RESEARCH QUESTION: What clinical factors are associated with 'unexpected' poor or suboptimal responses to IVF ovarian stimulation per POSEIDON's criteria, and which AMH and AFC threshold values distinguish this population? DESIGN: Tri-centre retrospective cohort study (2015-2017) involving first-time IVF and ICSI cycles with conventional ovarian stimulation (≥150 IU/day of FSH). Eligibility criteria included sufficient ovarian reserve markers according to POSEIDON's classification (AMH ≥1...
January 30, 2024: Reproductive Biomedicine Online
https://read.qxmd.com/read/38657238/investigating-rhythmicity-in-app-usage-to-predict-depressive-symptoms-protocol-for-personalized-framework-development-and-validation-through-a-countrywide-study
#3
JOURNAL ARTICLE
Md Sabbir Ahmed, Tanvir Hasan, Salekul Islam, Nova Ahmed
BACKGROUND: Understanding a student's depressive symptoms could facilitate significantly more precise diagnosis and treatment. However, few studies have focused on depressive symptom prediction through unobtrusive systems, and these studies are limited by small sample sizes, low performance, and the requirement for higher resources. In addition, research has not explored whether statistically significant rhythms based on different app usage behavioral markers (eg, app usage sessions) exist that could be useful in finding subtle differences to predict with higher accuracy like the models based on rhythms of physiological data...
April 24, 2024: JMIR Research Protocols
https://read.qxmd.com/read/38657223/spatial-dissection-of-the-immune-landscape-of-solid-tumors-to-advance-precision-medicine
#4
JOURNAL ARTICLE
Francesco Di Mauro, Giuseppina Arbore
Chemotherapeutics, radiation, targeted therapeutics and immunotherapeutics each demonstrate clinical benefits for a small subset of patients with solid malignancies. Immune cells infiltrating the tumor and the surrounding stroma play a critical role in shaping cancer progression and modulating therapy response. They do this by interacting with the other cellular and molecular components of the tumor microenvironment (TME). Spatial multi-OMICs technologies are rapidly evolving. Currently, such technologies allow high-throughput RNA and protein profiling and retain geographical information about the TME cellular architecture and the functional phenotype of tumor, immune and stromal cells...
April 24, 2024: Cancer Immunology Research
https://read.qxmd.com/read/38657189/influence-of-preoperative-anatomy-and-functional-status-on-outcomes-after-total-temporomandibular-joint-replacement-with-patient-specific-endoprostheses-a-retrospective-cohort-study
#5
JOURNAL ARTICLE
Rostyslav Terletskyi, Krzysztof Dowgierd, Yurii Chepurnyi, Andrii Kopchak, Andreas Neff
BACKGROUND: Temporomandibular joint (TMJ) replacement may be indicated for various pathological conditions, and the type of condition can affect the surgical procedure and outcomes. The causes of limited range of motion after alloplastic TMJ replacement have not been extensively studied. OBJECTIVES: The present study aimed to evaluate the impact of preoperative jaw anatomy and functional status on the immediate and long-term outcomes of total TMJ replacement using a two-component patient-specific TMJ endoprosthesis...
April 24, 2024: Dental and Medical Problems
https://read.qxmd.com/read/38657187/-nectin4-amplification-is-frequent-in-solid-tumors-and-predicts-enfortumab-vedotin-response-in-metastatic-urothelial-cancer
#6
JOURNAL ARTICLE
Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz, Oliver Hahn, Thomas Büttner, Florian Roghmann, Christian Bolenz, Friedemann Zengerling, Constantin Schwab, Dora Nagy, Marieta Toma, Glen Kristiansen, Hendrik Heers, Philipp Ivanyi, Günter Niegisch, Camilla Marisa Grunewald, Christopher Darr, Arian Farid, Katrin Schlack, Mahmoud Abbas, Can Aydogdu, Jozefina Casuscelli, Theresa Mokry, Michael Mayr, Dora Niedersüß-Beke, Steffen Rausch, Dimo Dietrich, Jonas Saal, Jörg Ellinger, Manuel Ritter, Abdullah Alajati, Christoph Kuppe, Joshua Meeks, Francisco E Vera Badillo, J Alberto Nakauma-González, Joost Boormans, Kerstin Junker, Arndt Hartmann, Viktor Grünwald, Michael Hölzel, Markus Eckstein
PURPOSE: The anti-NECTIN4 antibody-drug conjugate enfortumab vedotin (EV) is approved for patients with metastatic urothelial cancer (mUC). However, durable benefit is only achieved in a small, yet uncharacterized patient subset. NECTIN4 is located on chromosome 1q23.3, and 1q23.3 gains represent frequent copy number variations (CNVs) in urothelial cancer. Here, we aimed to evaluate NECTIN4 amplifications as a genomic biomarker to predict EV response in patients with mUC. MATERIALS AND METHODS: We established a NECTIN4 -specific fluorescence in situ hybridization (FISH) assay to assess the predictive value of NECTIN4 CNVs in a multicenter EV-treated mUC patient cohort (mUC-EV, n = 108)...
April 24, 2024: Journal of Clinical Oncology
https://read.qxmd.com/read/38657155/predicting-microwave-ablation-early-efficacy-in-pulmonary-malignancies-via-%C3%AE-radiomics-models
#7
JOURNAL ARTICLE
Jing Yang, Chen Yang, Jianju Feng, Fandong Zhu, Zhenhua Zhao
OBJECTIVE: This study aimed to explore the value of preoperative and postoperative computed tomography (CT)-based radiomic signatures and Δ radiomic signatures for evaluating the early efficacy of microwave ablation (MWA) for pulmonary malignancies. METHODS: In total, 115 patients with pulmonary malignancies who underwent MWA treatment were categorized into response and nonresponse groups according to relevant guidelines and consensus. Quantitative image features of the largest pulmonary malignancies were extracted from CT noncontrast scan images preoperatively (time point 0, TP0) and immediately postoperatively (time point 1, TP1)...
April 24, 2024: Journal of Computer Assisted Tomography
https://read.qxmd.com/read/38657086/an-hiv-1-risk-assessment-tool-for-women-aged-15-49-in-african-countries-a-pooled-analysis-across-15-nationally-representative-surveys
#8
JOURNAL ARTICLE
Nora E Rosenberg, Bonnie E Shook-Sa, Amber M Young, Yating Zou, Lynda Stranix-Chibanda, Marcel Yotebieng, Nadia A Sam-Agudu, Sam J Phiri, Wilbroad Mutale, Linda-Gail Bekker, Manhattan E Charurat, Sizulu Moyo, Khangelani Zuma, Jessica Justman, Michael G Hudgens, Benjamin H Chi
BACKGROUND: Women in Africa disproportionately acquire HIV-1. Understanding which women are most likely to acquire HIV-1 can guide focused prevention with pre-exposure prophylaxis (PrEP). Our objective is to identify women at highest risk of HIV-1 and estimate PrEP efficiency at different sensitivity levels. METHODS: Nationally representative data were collected from 2015-2019 from 15 population-based household surveys. This analysis included women aged 15-49 who tested HIV-1 sero-negative or had recent HIV-1...
April 24, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38656987/development-and-validation-of-a-nomogram-for-predicting-28-day-mortality-in-patients-with-ischemic-stroke
#9
JOURNAL ARTICLE
Lingyan Fang, Menglu Zhou, Fengkai Mao, Mengyuan Diao, Wei Hu, Guangyong Jin
BACKGROUND/AIM: We aimed to construct a validated nomogram model for predicting short-term (28-day) ischemic stroke mortality among critically ill populations. MATERIALS AND METHODS: We collected raw data from the Medical Information Mart for Intensive Care IV database, a comprehensive repository renowned for its depth and breadth in critical care information. Subsequently, a rigorous analytical framework was employed, incorporating a 10-fold cross-validation procedure to ensure robustness and reliability...
2024: PloS One
https://read.qxmd.com/read/38656906/comparative-pharmacokinetic-assessment-of-innovative-sublingual-rectal-and-vaporizer-cannabis-products-versus-approved-cannabis-products-in-healthy-volunteers
#10
JOURNAL ARTICLE
Sheina Tarlovski, Anat Bar Kadmon, Eran Goldberg, Dadi Segal, Dov Gavish, David Stepensky
Background: Over the last years, there is a dramatic increase in the use of medical cannabis products for an expanding range of clinical indications. The type of the drug product and its administration route affect substantially the rate and the extent of absorption of cannabinoids and the effects induced by them in the patients. The current challenge for the cannabis pharmaceutical industry is to develop formulations that allow predictable and stable absorption of cannabinoids. This article reports the results of the clinical trial that investigated the pharmacokinetics (PKs) of innovative cannabis products in healthy volunteers...
April 24, 2024: Cannabis and Cannabinoid Research
https://read.qxmd.com/read/38656833/gene-expression-assays-to-tailor-adjuvant-endocrine-therapy-for-hr-her2-breast-cancer
#11
JOURNAL ARTICLE
Michele Bottosso, Federica Miglietta, Grazia Maria Vernaci, Tommaso Giarratano, Maria Vittoria Dieci, Valentina Guarneri, Gaia Griguolo
Adjuvant endocrine therapy represents the standard of care for almost all HR+/HER2- breast cancers and different agents and durations are currently available. In this context, the tailoring and optimization of adjuvant endocrine treatment by reducing unnecessary toxic treatment while taking into account the biological heterogeneity of HR+/HER2- breast cancer represents a clinical priority. There is therefore a significant need for the integration of biological biomarkers in the choice of adjuvant endocrine therapy beyond currently used clinicopathological characteristics...
April 24, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38656810/advancements-in-the-application-of-uterine-ultrasound-elastography
#12
REVIEW
Francesca Barrett, Stephanie Willson, Marie Werner
PURPOSE OF REVIEW: This article reviews recent advances in ultrasound elastography in diagnosing and evaluating the normal nongravid uterus and the infertile uterus in the gynecologic patient. RECENT FINDINGS: Focusing on the most recent primary literature, studies have demonstrated new findings among a breadth of gynecologic clinical settings. Studies in the nongravid uterus have found that menopausal status, age, and menstrual phase have not been associated with changes in uterine tissue stiffness...
June 1, 2024: Current Opinion in Obstetrics & Gynecology
https://read.qxmd.com/read/38656790/changed-sleep-according-to-weighted-blanket-adherence-in-a-16-week-sleep-intervention-among-children-with-attention-deficit-hyperactivity-disorder
#13
JOURNAL ARTICLE
Maria Lönn, Petra Svedberg, Jens Nygren, Håkan Jarbin, Katarina Aili, Ingrid Larsson
STUDY OBJECTIVES: To examine differences in sample characteristics and longitudinal sleep outcomes according to weighted blanket adherence. METHODS: Children with attention-deficit/hyperactivity disorder (ADHD) (n =94), mean age 9.0 (sd 2.2, range 6-14) participated in a 16-week sleep intervention with weighted blankets (WB). Children were classified as WB adherent (use of WB ≥ 4 nights/week) or non-adherent (use of WB ≤ 3 nights/week). Changes in objectively measured sleep by actigraphy, parent-reported sleep problems (Children's Sleep Habits Questionnaire (CSHQ)) and child-reported Insomnia Severity Index (ISI) were evaluated according to adherence with mixed effect models...
April 24, 2024: Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine
https://read.qxmd.com/read/38656751/circulating-myostatin-levels-as-a-prognostic-biomarker-in-patients-with-acute-liver-failure-and-late-onset-hepatic-failure
#14
JOURNAL ARTICLE
Manabu Hayashi, Kazumichi Abe, Tatsuro Sugaya, Yosuke Takahata, Masashi Fujita, Atsushi Takahashi, Hiromasa Ohira
AIM: Myostatin is a myokine involved in muscle mass regulation. The associations between circulating myostatin levels and clinical characteristics in patients with acute liver failure (ALF) and late-onset hepatic failure (LOHF) are unclear. METHODS: In this retrospective study, 51 patients with ALF or LOHF were included. Serum myostatin was measured using an enzyme-linked immunosorbent assay. RESULTS: Myostatin levels were significantly lower in patients with ALF and LOHF than in controls (ALF/LOHF: 2522 pg/mL, controls: 3853 pg/mL, p = 0...
April 24, 2024: Hepatology Research: the Official Journal of the Japan Society of Hepatology
https://read.qxmd.com/read/38656745/clinicopathological-importance-of-bcl-2-and-p53-in-postmenopausal-triple-negative-breast-carcinoma-and-association-with-age
#15
JOURNAL ARTICLE
Kei Ito, Naoko Honma, Hideaki Ogata, Akimitsu Yamada, Mika Miyashita, Tomio Arai, Eiichi Sasaki, Kazutoshi Shibuya, Tetuo Mikami, Masataka Sawaki
Appropriate biomarkers are required to predict the clinical outcome of triple-negative breast cancer (TNBC). In this study, we focused on the clinical importance of two representative tumor-associated proteins, Bcl-2 and p53. Bcl-2 expression is usually related to estrogen receptor expression and a favorable outcome in breast cancer. TNBC has been reported to show a high frequency of p53 positivity suggesting TP53 mutations. The expressions of Bcl-2 and p53 were immunohistochemically examined in TNBC involving two age groups of postmenopausal women (≥75 y/o, n = 75; 55-64 y/o, n = 47), who underwent surgery without neoadjuvant therapy...
April 24, 2024: Pathology International
https://read.qxmd.com/read/38656744/-molecular-subtypes-provide-possibilities-for-precision-medicine-in-a-advanced-prostate-cancer
#16
REVIEW
Pernilla Wikström, Anders Bergh, Andreas Josefsson, Elin Thysell, Karin Welén
Increased molecular knowledge makes it possible to consider not only genetic defects but also expression profiles for precision medicine in advanced prostate cancer. Several prognostic and treatment-predictive classifiers for prostate cancer have been described, such as Prolaris, OncotypeDx, Decipher, Prostatype, PAM50, PCS1-2, and MetA-C, which all build upon transcript profiles. In research studies, the MetA-C classifier has shown clear prognostic information for patients with metastatic disease, in relation to outcome after androgen receptor targeting therapies, and so has immunohistochemical evaluation of tumor cell proliferation (Ki67) and PSA expression...
April 24, 2024: Läkartidningen
https://read.qxmd.com/read/38656732/role-of-triglyceride-glucose-index-in-metabolic-assessment-of-sarcoidosis-patients
#17
JOURNAL ARTICLE
Luigi Rizzi, Chiara Coppola, Yaqob Hbaidi, Riccardo Russo, Lucilla Crudele, Antonio Moschetta, Patrizia Suppressa
Sarcoidosis is a rare granulomatous disease that can affect any organ. It leads to an increased risk of metabolic syndrome and insulin resistance, due to biochemical pathways involved in low-grade inflammation in both diseases. The aim of our retrospective case-control study was to evaluate the utility of triglyceride-glucose (TyG) index, a surrogate of insulin resistance, for metabolic assessment of sarcoidosis patients. A cohort of 90 sarcoidosis patients and a cohort of 90 control subjects were enrolled...
April 24, 2024: Internal and Emergency Medicine
https://read.qxmd.com/read/38656728/integrative-analyses-of-bulk-and-single-cell-rna-seq-identified-the-shared-genes-in-acute-respiratory-distress-syndrome-and-rheumatoid-arthritis
#18
JOURNAL ARTICLE
Jun Shi, Jiajia Tang, Lu Liu, Chunyang Zhang, Wei Chen, Man Qi, Zhihai Han, Xuxin Chen
Acute respiratory distress syndrome (ARDS), a progressive status of acute lung injury (ALI), is primarily caused by an immune-mediated inflammatory disorder, which can be an acute pulmonary complication of rheumatoid arthritis (RA). As a chronic inflammatory disease regulated by the immune system, RA is closely associated with the occurrence and progression of respiratory diseases. However, it remains elusive whether there are shared genes between the molecular mechanisms underlying RA and ARDS. The objective of this study is to identify potential shared genes for further clinical drug discovery through integrated analysis of bulk RNA sequencing datasets obtained from the Gene Expression Omnibus database, employing differentially expressed genes (DEGs) analysis and weighted gene co-expression network analysis (WGCNA)...
April 24, 2024: Molecular Biotechnology
https://read.qxmd.com/read/38656714/carboxyhemoglobin-predicts-oxygenator-performance-and-imminent-oxygenator-change-in-extracorporeal-membrane-oxygenation
#19
JOURNAL ARTICLE
Rolf Erlebach, Alix Buhlmann, Rea Andermatt, Benjamin Seeliger, Klaus Stahl, Christian Bode, Reto Schuepbach, Pedro David Wendel-Garcia, Sascha David
BACKGROUND: The continuous exposure of blood to a non-biological surface during extracorporeal membrane oxygenation (ECMO) may lead to progressive thrombus formation in the oxygenator, hemolysis and consequently impaired gas exchange. In most centers oxygenator performance is monitored only on a once daily basis. Carboxyhemoglobin (COHb) is generated upon red cell lysis and is routinely measured with any co-oximetry performed to surveille gas exchange and acid-base homeostasis every couple of hours...
April 24, 2024: Intensive Care Medicine Experimental
https://read.qxmd.com/read/38656685/circulating-tumor-dna-in-diffuse-large-b-cell-lymphoma-from-bench-to-bedside
#20
REVIEW
Hua-Jay J Cherng, Alex Herrera
Diffuse large B-cell lymphoma (DLBCL) is a curable disease with variable outcomes due to underlying heterogeneous clinical and molecular features-features that are insufficiently characterized with our current tools. Due to these limitations, treatment largely remains a "one-size-fits-all" approach. Circulating tumor DNA (ctDNA) is a novel biomarker in cancers that is increasingly utilized for risk stratification and response assessment. ctDNA is readily detectable from the plasma of patients with DLBCL but has not yet been incorporated into clinical care to guide treatment...
April 24, 2024: Current Treatment Options in Oncology
keyword
keyword
39472
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.